If you are having trouble viewing this message or would like to share it on a social network, you can view the message online.
HOME  |   ABOUT  |   SERVICES  |   ISSUES  |   MEDIA  |   OUR DISTRICT  |   CONTACT
December 13, 2019

McKinley Calls for a Bipartisan Solution to Lower Prescription Drug Prices

Senate leadership has said they will not vote on H.R. 3, and President Trump made it clear he would veto it. So, If lowering the cost of prescriptions were really a priority for Democrats, they would have voted to adopt H.R. 19 – the bipartisan amendment— instead of the politically charged bill H.R.3.

H.R. 19 has 35 bipartisan provisions that have passed out of House committees and it includes 90% of the bipartisan Grassley-Wyden bill in the Senate. This bipartisan alternative will not only lower drug prices, but it will protect innovation and research into new medicines and cures for diseases like Alzheimer's, rheumatoid arthritis, ALS, diabetes and Parkinson's.

The Congressional Budget Office, and the Council of Economic Advisors all concluded that H.R. 3 will prevent hundreds of new cures from entering the market,” McKinley said. “Therefore, I have to ask the supporters of H.R. 3, which cures for our loved ones are you willing to sacrifice?”

The Lower Costs, More Cures Act is a package of bills that have already pass out of House committees or the entire House with strong bipartisan support. This legislation is aimed at reducing the cost of prescription drugs without hindering the creation of new life-saving medicines. The bill uses bipartisan reforms to lower out-of-pocket spending, protect access to new medicines and cures, and strengthen transparency and accountability.


To watch McKinley’s full remarks click on the photo above

Combating Anti-Semitism
Anti-Semitism has no place in our society. I commend President Trump's Executive Order that furthers the fight against the rise of anti-Semitism in the United States.

To read President Trump's Executive Order Click here.

Energy & Commerce Innovation Showcase Highlights Touchstone Industries
I’m thrilled that TouchStone was able to be a part of today’s Energy and Commerce innovation showcase, and I look forward to showing other members just one of the great companies doing research in our state. Rather than simply banning or doing away with fossil fuels, America should be leading the charge with innovative way to utilize them cleanly. Companies like Touch Stone Research Lab, Net Power, and others featured at today’s showcase are going to have a major role in our energy future.


McKinley, Sewell Introduce Legislation to Expand Access to Non-Opioid Medications

Terri Sewell (AL-07) and I last month introduced the Non-Opioids Prevent Addiction in the Nation (NOPAIN) Act (H.R. 5172) today, legislation to help address barriers to non-opioid pain management for those enrolled in Medicare, thereby helping stem the opioid epidemic across the nation.“Currently, our healthcare payment system is unnecessarily encouraging the use of opioids. Our bill would ensure that CMS does not disincentivize the use of innovative non-opioid drugs and devices to treat and manage pain. While pain management for all patients should be handled individually, opioids should not be the first or only option given.


Interested in Interning in Our office?

We’d like to encourage students at any West Virginia college or University to apply for a Fall or Spring internship in our Washington, DC office! Internships run throughout the fall, spring, or summer semesters for college students. Our internships offer a monthly stipend and students gain invaluable work experience in the heart of our nation’s capital. The hours are flexible to accommodate students' hectic course schedules, but generally run 9:00 a.m. to 6:00 p.m. when Congress is in session, and 9:00 a.m. to 5:00 p.m. when not in session.

Please follow the link below to apply and reach out to my Washington, DC office with any questions!

https://mckinley.house.gov/forms/internships/


In The News This Week

State looks to receive additional millions in federal funds to battle opioid epidemic

West Virginia, 17 other states challenging US Circuit Court’s ruling on Atlantic Coast Pipeline

Christmas Gift Distribution Event Provides Assistance for Local Families                                                           


CONTACT INFORMATION

Washington D.C. Office
2239 Rayburn HOB | Washington, DC 20515
Phone: (202) 225-4172 | Fax: (202) 225-7564
Morgantown Office
709 Beechurst Ave., Suite 29
Morgantown, WV 26805
Phone: (304) 284-8506
Fax: (304) 284-8505
Parkersburg Office
408 Market Street
Parkersburg, WV 26101
Phone: (304) 422-5972
Fax: (304) 422-5974
Wheeling Office
Horne Building 1100 Main Street
Suite 101
Wheeling, WV 26003
Phone: (304) 232-3801
Fax: 304-232-3813

STAY CONNECTED

     
Update My Profile | Contact